Jul 2026· Uttar Pradesh Journal of Zoology· Vol 47, pp. 51-72· 0 citations
TL;DR
It is concluded that CRISPR-based functional genomics has reshaped zoological enquiry in ways unlikely to be reversed, yet its translation into field-deployed conservation and agricultural interventions remains constrained by incomplete ecological risk assessment, uneven regulatory harmonisation, and the biological idiosyncrasies of non-model taxa that resist easy extrapolation from laboratory systems.
Abstract
The advent of CRISPR–Cas genome editing has changed the study of animal biology, turning functional genomics from a discipline constrained by slow forward-genetic screens and bespoke, species-specific reagents into one capable of rapid, programmable, and broadly portable genetic manipulation. This review critically synthesises the past decade of progress in applying CRISPR-based tools across zoology, spanning classical vertebrate model organisms, emerging non-model invertebrates, livestock and aquaculture species, and wildlife populations of direct conservation concern. We examine the expanding molecular toolkit, from nuclease-mediated knockouts through base and prime editing to transcriptional and epigenetic modulation, and consider how these tools have been adapted to taxa as different as zebrafish, cephalopods, reef-building corals, lepidopteran insects, poultry, and large-bodied mammals. Particular attention is given to three areas where functional genomics meets applied zoology and conservation biology most directly: genetic rescue and de-extinction science aimed at restoring genetic diversity or ecological function to imperilled or vanished species; gene drive technologies designed to suppress or modify wild populations of disease vectors and invasive pests; and genome-edited livestock, poultry, and aquaculture stocks engineered for disease resistance, welfare improvement, and production efficiency. We further evaluate methodological advances in detecting and mitigating off-target mutagenesis, the welfare and biosafety implications of intentionally altering the genomes of sentient animals, and the evolving regulatory landscape governing genome-edited organisms in agriculture, biomedicine, and the environment. Throughout, we take a critical stance, weighing demonstrated efficacy against persistent technical limitations, ecological uncertainty, and unresolved ethical questions. We conclude that CRISPR-based functional genomics has reshaped zoological enquiry in ways unlikely to be reversed, yet its translation into field-deployed conservation and agricultural interventions remains constrained by incomplete ecological risk assessment, uneven regulatory harmonisation, and the biological idiosyncrasies of non-model taxa that resist easy extrapolation from laboratory systems.
This article synthesizes contemporary advancements in CRISPR-mediated mammalian genome modification, detailing core mechanisms – such as guide RNA and the Cas9 endonuclease – alongside next-generation modalities, including base and prime editing.
Olga Aldoshina, Dmitriy Lazarev, E. Smirnova· Veterinariya, Zootekhniya i...· 0 citations
The potential application of CRISPR technology for the possible management of geneticbased conditions, including sickle-cell anemia, β-thalassemia, cystic fibrosis, and Duchenne muscular dystrophy is described.
M. Veer, Poonam Nikam, Omkar More et al.· International Journal of Dru...· 0 citations
The convergence of CRISPR-Cas9 genome editing and nanozyme engineering is revolutionizing synthetic biology, biotechnology, and medical science. CRISPR-Cas9, a precise and programmable tool, enables targeted genetic modifications that enhance nanozyme functionality, stability, and catalytic efficiency. Through the site-specific mutagenesis, metabolic pathway regulation, and synthetic biology strategies, researchers have significantly improved nanozyme performance for diverse applications, including environmental remediation, biomedical diagnostics, and industrial catalysis. This article explores the fundamental mechanisms of CRISPR-based genome editing, its role in nanozyme optimization, and the latest breakthroughs in enzyme engineering. It also critically examines challenges such as off-target effects, biosafety concerns, and ethical implications associated with gene-edited nanozymes. As advancements in AI-driven predictive modeling and next-generation gene-editing tools emerge, CRISPR-Cas9 is poised to unlock unprecedented possibilities in bioengineering. The integration of genetic precision with catalytic innovation marks a transformative era, redefining the frontiers of molecular biotechnology and paving the way for groundbreaking applications in medicine, industry, and sustainable technology.
Modamori I.O, Okanlawon T.S, Ebhomienlen J.O et al.· Biological and Environmental...· 0 citations
This review provides a comprehensive synthesis of a recent advances in CRISPR–Cas technologies and their strategic applications in crop genetics and hybrid breeding, and showcases how these technologies accelerate hybrid breeding by engineering male sterility systems, fixing heterosis, and generating high-throughput mutant libraries for trait discovery.
Syed Riaz Ahmed, Jahangir Khan, I. Ijaz et al.· Frontiers in Plant Science· 0 citations
A consolidated guide for selecting suitable CRISPR-Cas technologies and underscoring important considerations for their continued development in leishmaniasis research is offered, highlighting the transition of CRISPR-Cas systems from proof-of-concept tools to versatile platforms for functional genomics, target validation and translational research in Leishmania.
A. Ata, Derya Topuz Ata· Molecular Biology Reports· 0 citations
A continued diversification of the CRISPR-based toolbox, robust interest in genome editing applications across the tree of life, maturation in terms of adoption, and rising relative distribution beyond the USA and China are reflected.
Alyssa Shepard, Elena Minones-Moyano, Christina Mork et al.· The CRISPR Journal· 0 citations